MARKET

PSNL

PSNL

Personalis
NASDAQ
15.88
-0.07
-0.44%
After Hours: 15.84 -0.04 -0.25% 17:28 11/10 EST
OPEN
15.88
PREV CLOSE
15.95
HIGH
16.07
LOW
15.81
VOLUME
1.76M
TURNOVER
--
52 WEEK HIGH
18.89
52 WEEK LOW
4.955
MARKET CAP
1.72B
P/E (TTM)
-13.6661
1D
5D
1M
3M
1Y
5Y
1D
Cathie Wood's Ark Invest buys $96M of SpaceX, adds to Nvidia and AMD; trims Broadcom
Seeking Alpha · 1d ago
Weekly Report: what happened at PSNL last week (1102-1106)?
Weekly Report · 1d ago
Personalis, Inc. Reports Q3 Clinical Test Volume of 13,157 and Overall Revenue of $25.6 million
NASDAQ · 6d ago
*Personalis 3Q Loss $33.8M >PSNL
Dow Jones · 6d ago
*Personalis 3Q Loss/Shr 32c >PSNL
Dow Jones · 6d ago
Cathie Wood Buys $3.6M of Coinbase Stock, Sells $5.4M of This Healthcare Stock
TipRanks · 11/03 11:30
Tempus AI's Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer
Barron‘s · 11/02 13:11
Weekly Report: what happened at PSNL last week (1026-1030)?
Weekly Report · 11/02 10:10
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.